*  Study of IMC-1121B in Patients With Advanced Solid Tumors - Full Text View - ClinicalTrials.gov
Number of Participants With Drug-Related Adverse Events [ Time Frame: Baseline to study completion up to 48 weeks ]. Data ... participants who have an objective response or stable disease may continue to receive IMC-1121B at the same dose and schedule ... and administration of steroids] is required, are permitted to enter the study.) ... This trial is testing the investigational drug IMC-1121B administered to Japanese participants with advanced solid tumors who ...
  https://clinicaltrials.gov/ct2/show/NCT01005355
*  Get Your Pre‑teen's Shots on Schedule - healthfinder.gov
Also, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) check vaccines every year ... Home , Health Topics A to Z , Pre-teens and Teens , Doctor Visits , Get Your Pre‑teen's Shots on Schedule ... Schedule a checkup for your pre-teen.. The meningococcal, HPV, and Tdap vaccines are given during your child's yearly checkup ...
  https://healthfinder.gov/HealthTopics/Population/pre-teens-and-teens/doctor-visits/get-your-pre-teens-shots-on-schedule
*  Pentagon's Top Weapons Tester: F-35 Still Challenged | Ares
Once again the program is NOT on schedule, it is on a schedule contrived by use of an imaginary start date, one selected to fit ... What's even worse is that the current administration has already DONE far worse, and lied about it, and made everything about ... contractors to not meet the terms of the contracts they sign but there are millions in extra revenue to be had by dragging them ... Cost & schedule misses are well known. Performance is short on a few KPIs but overall the F-35 is meeting spec and even ...
  http://aviationweek.com/blog/pentagons-top-weapons-tester-f-35-still-challenged?page=1
*  Process for determining drug taper schedules - Patent # 5468222 - PatentGenius
The process corrects for actual dosage sizes available, and calculates administration schedules for the patient and nurse. ... The process is based on an exponential drug taper. This is particularly useful for a drug which a patient is either physically ... The program calculates the amount of drug and provides the clinician the opportunity to look at several different possible drug ... and to aid the clinician in choosing the appropriate drug taper. The process can calculate a drug taper based upon actual ...
  http://www.patentgenius.com/patent/5468222.html
*  National Drugs and Poisons Schedule Committee (NDPSC) | Therapeutic Goods Administration (TGA)
... scheduling decisions were made by the National Drugs and Poisons Schedule Committee (NDPSC), an independent expert co ... National Drugs and Poisons Schedule Committee (NDPSC). Until 30 June 2010, scheduling decisions were made by the National Drugs ... Records of reasons from meetings of the National Drugs and Poisons Schedule Committee (NDPSC) ... Important notice regarding matters for consideration at the June 2010 meeting of the National Drugs and Poisons Scheduling ...
  https://www.tga.gov.au/committee/national-drugs-and-poisons-schedule-committee-ndpsc
*  Text of H.J.Res. 77 (113th): Food and Drug Administration Continuing Appropriations Resolution, 2014 (Placed on Calendar in the...
Placed on Calendar in the Senate version). H.J.Res. 77 (113th): Food and Drug Administration Continuing Appropriations ... 77 (113th): Food and Drug Administration Continuing ... as of Oct 9, 2013 ( ... Food and Drug Safety Act .. This joint resolution may be cited as the Food and Drug Administration Continuing Appropriations ... Department of Health and Human Services-Food and Drug Administration .. (b) The rate for operations provided by subsection (a) ...
  https://www.govtrack.us/congress/bills/113/hjres77/text
*  Interactions between δ and μ Opioid Agonists in Assays of Schedule-Controlled Responding, Thermal Nociception, Drug Self...
Single-Key Assay of Drug Self-Administration. For intravenous drug administration, a double-lumen catheter was implanted into a ... The ED50 value of the dose-effect curve for drug choice was defined as the dose of drug or drug mixture that produced 50% drug ... Drugs were administered i.m. in the thigh (schedule-controlled responding, thermal nociception) or i.v. (drug self- ... in assays of schedule-controlled responding for food reinforcement, thermal nociception, drug self-administration, and food ...
  http://jpet.aspetjournals.org/content/314/1/221
*  A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in...
Drug Therapy, Combination. Zidovudine. Drug Administration Schedule. Disease Transmission, Vertical. Reverse Transcriptase ...
  https://clinicaltrials.gov/show/NCT00000864?order=49
*  Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients - Full Text View - ClinicalTrials.gov
Drug Therapy, Combination. Drug Administration Schedule. Viremia. T-Lymphocytes, Cytotoxic. Anti-HIV Agents. Treatment ... Drug: Aldesleukin Subcutaneous injection of IL-2 in the amount of 2.0 X 10^6 mIU per day for the entire duration of therapy ... Drug: HAART Current HAART regimen to be continued for duration of therapy or until certain criteria specified by the study is ... Drug: HAART Current HAART regimen to be continued for duration of therapy or until certain criteria specified by the study is ...
  https://www.clinicaltrials.gov/ct2/show/NCT00001131
*  The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP) - Full Text View -...
Drug Administration Schedule. Nucleoside Reverse Transcriptase Inhibitors. Pharmacokinetics. Additional relevant MeSH terms: ... Drug: Daily dosing Drug: Time-driven dosing Drug: Event-driven dosing Phase 2 ... Only the cross table between drug resistance by arm are presented here. See outcome measure 11 for the listing of plasma HIV ... A Listing, by Arm, of Drug Resistance Test Results and Plasma HIV RNA Levels Among All Participants Who Seroconvert While on ...
  https://clinicaltrials.gov/show/NCT01327651?order=107
*  A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation - Full Text View -...
Drug Administration Schedule. Stavudine. HIV Protease Inhibitors. Ritonavir. Reverse Transcriptase Inhibitors. Self Care. Viral ... Drug: lopinavir/ritonavir Drug: emtricitabine Drug: stavudine Drug: tenofovir DF Phase 2 ... In Arm C, drugs are taken once a day under directly observed therapy during Weeks 0-24, and then by self-administration during ... Anti-HIV drug therapy works best when the drugs are taken exactly as prescribed by a doctor. Because anti-HIV therapy often ...
  https://clinicaltrials.gov/show/NCT00036452?order=253
*  Safety and Efficacy Study of Carvedilol to Treat Children With Congestive Heart Failure - Full Text View - ClinicalTrials.gov
Drug Administration Schedule. Female. Heart Failure, Congestive/etiology. Heart Failure, Congestive/drug therapy. Heart Failure ... Use of an investigational drug within 30 days of randomization, or within 5 half-lives of the investigational drug (the longer ... Adrenergic beta-Antagonists/administration & dosage. Age Factors. Carbazoles/therapeutic use. Carbazoles/administration & ... If intolerance has been established, the patient must have been withdrawn from these drugs for at least one month prior to ...
  https://clinicaltrials.gov/show/NCT00052026
*  Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI) - Full Text View - ClinicalTrials.gov
Drug Therapy, Combination. Drug Administration Schedule. Stavudine. HIV Protease Inhibitors. Nelfinavir. Reverse Transcriptase ... Didanosine is an effective anti-HIV drug, but it can cause stomach upset. This study tests a new form of didanosine, ddI EC, a ...
  https://clinicaltrials.gov/ct2/show/study/NCT00002224?show_locs=Y
*  Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV...
Drug Therapy, Combination. Drug Administration Schedule. Reverse Transcriptase Inhibitors. Anti-HIV Agents. Pharmacokinetics. ... Drug: Didanosine (ddI) Drug: Efavirenz (EFV) Drug: Emtricitabine (FTC) Phase 1 Phase 2 ... Treatment of HIV-infected patients involves combining drugs from different classes of anti-HIV drugs. One preferred regimen for ... Drug: Efavirenz (EFV) Antiretroviral For Age Group 1 Efavirenz (EFV): dose adjusted for body size and for Age Groups 2 and 3 ...
  https://clinicaltrials.gov/show/NCT00016718?order=259
*  Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV...
Drug Therapy, Combination. Zidovudine. Drug Administration Schedule. Lamivudine. Genotype. Phenotype. Reverse Transcriptase ... Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV ... Abuse alcohol or drugs to an extent that may make study participation difficult. ... once a day versus twice a day as part of an anti-HIV drug combination. ...
  https://clinicaltrials.gov/show/NCT00004852?order=196
*  Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy - Full Text View -...
Drug Administration Schedule. CD4 Lymphocyte Count. Anti-HIV Agents. Viral Load. Treatment Interruption. Treatment Experienced ... Anti-HIV drug regimen of at least 3 anti-HIV drugs for at least 6 months immediately prior to study entry ... Current use of experimental anti-HIV drugs other than FDA sanctioned investigational drugs ... Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy. This study has been ...
  https://clinicaltrials.gov/show/NCT00038259?order=198
*  Zidovudine and Lamivudine Given Once Versus Twice Daily - Full Text View - ClinicalTrials.gov
Drug Administration Schedule. Lamivudine. Reverse Transcriptase Inhibitors. Anti-HIV Agents. Pharmacokinetics. Combivir. ... This is a study of 2 schedules of Combivir therapy. At study entry or Part I, all patients take Combivir twice daily for the 7- ... The body also breaks down 3TC, a drug that is combined with ZDV in the Combivir product, in a similar way. Since antiviral ... Have taken at least 4 weeks of 3 or more anti-HIV medications, which must include ZDV and 3TC (as individual drugs or Combivir ...
  https://clinicaltrials.gov/show/NCT00014014?order=266
*  Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients -...
Drug Therapy, Combination. Drug Administration Schedule. RNA, Viral. Anti-HIV Agents. Viral Load. ... Have been on stable anti-HIV therapy for at least 8 weeks with no more than 4 anti-HIV drugs at the time of study entry. ... The purpose of this study is to see if giving tenofovir DF plus a combination of other anti-HIV drugs is safe and effective. ... While on study drug, patients are monitored for safety using periodic physical examinations and serial laboratory tests. ...
  https://clinicaltrials.gov/show/NCT00002450?order=31
*  A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in...
Drug Administration Schedule. CD4 Lymphocyte Count. Quality of Life. Anti-HIV Agents. ... Drug: Indinavir sulfate Drug: Lamivudine Drug: Stavudine Drug: Zidovudine Drug: Didanosine Drug: Aldesleukin Phase 2 ... Patients must be able to initiate one of the following nucleoside analogue regimens of which at least one of the drugs must be ... Ability to initiate one of the following nucleoside analogue regimens of which one of the drugs must be new to the patient: ...
  https://clinicaltrials.gov/show/NCT00000870?order=274
*  Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048 - Full Text...
Drug Administration Schedule. Drug Resistance, Microbial. Carrier State. Streptococcus pneumoniae. Additional relevant MeSH ... germs that grow despite the presence of drugs used to kill them). The purpose of this study is to see if people who take ... the bacteria can become resistant to the drugs. MAC preventive therapy uses antibiotics, but this can make it difficult to ...
  https://clinicaltrials.gov/show/NCT00000933?order=535
*  Propofol - Wikipedia
Even so, as of 2016 propofol was not on a U.S Drug Enforcement Administration schedule. One of propofol's most frequent side ... The US Food and Drug Administration approved the product in 2008. However fospropofol is a Schedule IV controlled substance ... Recreational use of the drug via self-administration has been reported, but is relatively rare due to its potency and the level ... "Drugs@FDA: FDA Approved Drug Products". Accessdata.fda.gov. Archived from the original on 5 September 2014. Retrieved 8 June ...
  https://en.wikipedia.org/wiki/Propofol
*  Ancient Iranian medicine - Wikipedia
Physicians stress the importance of dose, and route of administration and define a schedule for drug administration. Recent ... An antiepileptic drug-therapy plan in medieval Iranian medicine is individualized, given different single and combined drug- ... therapy with a dosing schedule for each of those. ...
  https://en.wikipedia.org/wiki/Ancient_Iranian_medicine
*  Noracymethadol - Wikipedia
"Controlled Substances in Schedule I". Drug Enforcement Administration - Office of Diversion Control. Retrieved 2012-05-11. ... Similarly to many of its analogues, noracymethadol is a Schedule I controlled substance in the United States with an ACSCN of ... and is also controlled internationally under the United Nations Single Convention on Narcotic Drugs of 1961. The salts known ... Thomas Nordegren (1 March 2002). The A-Z Encyclopedia of Alcohol and Drug Abuse. Universal-Publishers. p. 468. ISBN 978-1-58112 ...
  https://en.wikipedia.org/wiki/Noracymethadol
*  AH-7921 - Wikipedia
"Schedules of Controlled Substances: Placement of AH-7921 Into Schedule I". Drug Enforcement Administration. 14 April 2016. ... must be registered by the Drug Enforcement Administration. The Canadian Controlled Drugs and Substances Act was amended in 2016 ... In the UK, AH-7921 was included as a Class A drug in January 2015 as part of The Misuse of Drugs Act 1971 (Amendment) (No. 2) ... Further, Health Canada amended the Food and Drug Regulations in May, 2016 to classify AH-7921 as a restricted drug. Only those ...
  https://en.wikipedia.org/wiki/AH-7921
*  ADB-CHMINACA - Wikipedia
Temporary Placement of the Synthetic Cannabinoid MAB-CHMINACA Into Schedule I". Drug Enforcement Administration. 16 September ... ADB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015 ... The DEA announced its intent to place ADB-CHMINACA into Schedule I of the USA Controlled Substances Act on September 16, 2015. ... doi:10.1007/s11419-015-0272-y. Alan Schwarz (24 April 2015). "Potent 'Spice' Drug Fuels Rise in Visits to Emergency Room". The ...
  https://en.wikipedia.org/wiki/ADB-CHMINACA